Trademark: 87126892
Word
XEMYS
Status
Registered
Status Code
700
Status Date
Tuesday, May 8, 2018
Serial Number
87126892
Registration Number
5461700
Registration Date
Tuesday, May 8, 2018
Mark Type
4000
Filing Date
Thursday, August 4, 2016
Published for Opposition
Tuesday, February 20, 2018

Trademark Owner History
AS Kevelt - Original Registrant

Classifications
5 Biological preparations for the treatment of multiple sclerosis; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of multiple sclerosis or prevention of relapses of multiple sclerosis; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; human vaccine preparations; hormones; medical preparations for the treatment of multiple sclerosis; medicaments for delaying of multiple sclerosis progression and reduce of multiple sclerosis relapses; mixed biological preparations for the prevention and treatment of infectious diseases; mixed hormone preparations; molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; multivitamin preparations; multi-vitamin preparations; nasal and oral spray preparations for use as central nervous system stimulants; nasal spray preparations; nose drops; pain relief medication; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention of relapses of multiple sclerosis; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of multiple sclerosis; pharmaceutical preparations for treatment of multiple sclerosis or prevention of relapses of multiple sclerosis; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; preparation for the relief of pain; reagents for medical use; steroids; synthetic peptides for the treatment of multiple sclerosis; therapeutic pharmaceutical for the treatment of multiple sclerosis; vaccine preparations; vaccines; vitamin and mineral preparations for medical use; vitamins

Trademark Events
May 8, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 8, 2018
Registered-Principal Register
Feb 20, 2018
Official Gazette Publication Confirmation E-Mailed
Feb 20, 2018
Published For Opposition
Jan 31, 2018
Notification Of Notice Of Publication E-Mailed
Jan 18, 2018
Electronic Record Review Complete
Jan 12, 2018
On Hold - Electronic Record Review Required
Jan 9, 2018
Approved For Pub - Principal Register
Dec 29, 2017
Teas/Email Correspondence Entered
Dec 29, 2017
Correspondence Received In Law Office
Dec 22, 2017
Teas Response To Suspension Inquiry Received
Jun 24, 2017
Notification Of Inquiry As To Suspension E-Mailed
Jun 24, 2017
Inquiry To Suspension E-Mailed
Jun 24, 2017
Suspension Inquiry Written
May 31, 2017
Suspension Checked ¿ To Attorney For Action
May 24, 2017
Assigned To Lie
Nov 18, 2016
Notification Of Letter Of Suspension E-Mailed
Nov 18, 2016
Letter Of Suspension E-Mailed
Nov 18, 2016
Suspension Letter Written
Nov 16, 2016
Assigned To Examiner
Aug 8, 2016
New Application Office Supplied Data Entered
Aug 8, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24